Deferred Tax Assets, Operating Loss Carryforwards in USD of Renalytix plc from Q2 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
Renalytix plc quarterly Deferred Tax Assets, Operating Loss Carryforwards history and change rate from Q2 2018 to Q2 2024.
  • Renalytix plc Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 30 Jun 2024 was $46M, a 21.8% increase year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)

Renalytix plc Quarterly Deferred Tax Assets, Operating Loss Carryforwards (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2024 $46M +$8.22M +21.8% 30 Jun 2024 10-K 30 Sep 2024
Q2 2023 $37.7M +$10.5M +38.7% 30 Jun 2023 10-K 30 Sep 2024
Q2 2022 $27.2M +$13.7M +102% 30 Jun 2022 10-K 28 Sep 2023
Q2 2021 $13.5M +$9.2M +214% 30 Jun 2021 20-F 31 Oct 2022
Q2 2020 $4.3M +$2.46M +134% 30 Jun 2020 20-F 31 Oct 2022
Q2 2019 $1.83M +$1.67M +1024% 30 Jun 2019 20-F/A 01 Aug 2022
Q2 2018 $163K 30 Jun 2018 20-F/A 10 Nov 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.